Latest News

A letter published today in the New England Journal of Medicine reports on the long-term outcomes of patients from two ITN-sponsored combined kidney and bone marrow transplantation studies led by David H. Sachs, MD (Massachusetts General Hospital), Tatsuo Kawai, MD, PhD (Massachusetts General Hospital), Megan Sykes, MD (Columbia University) and A. Benedict Cosimi, MD (Massachusetts General Hospital).

Three abstracts from the ITN’s RAVE study (Rituximab for the Treatment of ANCA-Associated Vasculitis and Microscopic Polyangiitis) led by John Stone, MD (Massachusetts General Hospital) and Ulrich Specks, MD (Mayo Clinic) were presented this week by the RAVE team at the 16th International Vasculitis & ANCA Workshop in Paris, France.

A March 6, 2013 Wall Street Journal article, “Food Allergy Advice for Kids: Don’t Delay Peanuts, Eggs”, discusses the changing landscape surrounding food allergy prevention, citing the Immune Tolerance Network’s (ITN’s) LEAP study as a pivotal effort in determining whether the early introduction of allergenic foods may actually help prevent the development of allergies.

The Immune Tolerance Network (ITN) and Imperial College London are collaborating on a new pilot study examining immunological responses to cat allergen. Allergy to cat dander is one of the most common forms of allergic disease in the US and Europe, and can reduce the quality of life for allergy sufferers. The only form of disease-modifying therapy that does not just treat symptoms is immunotherapy, in which cat allergens are administered over a period of time to desensitize a patient.